Close

taxonomy for: BIO IPCC Conference

Event Schedule

Monday, November 18

Registration Open
1:00 pm - 4:30 pm

IPCC Business Meeting & Working Luncheon*
​*Open to IP Counsels Committee company members only
12:00 pm - 3:00 pm 

Refreshment Break
3:00 pm - 3:30 pm

Education Session 1: Who Owns That Patent? Do Your Interactions with Others Jeopardize Your Patent Ownership?
3:30 pm - 4:45 pm
Sponsored by McNeill Baur

Who Owns That Patent? Do Your Interactions with Others Jeopardize Your Patent Ownership?

Patent rights form the backbone of many companies’ business plans and yet companies often do not adequately consider the risks to their patent estate when they interact with third parties. This panel will discuss how third-party interactions can jeopardize a company’s exclusive patent ownership. We will review recent inventorship caselaw and surprising ownership-altering results after interactions with third parties. We will also discuss:

  • Troublesome factual situations and how to manage agreements with third parties;
  • how potential inventorship and ownership scenarios impact drafting and prosecution strategies; and
  • evaluating third party patents and detecting inventorship/ownership problems (FTO, litigation).

Moderator and Speaker
Rebecca M. McNeill, Founding Partner, McNeill Baur

Speakers:
Adam M. Breier, PhD, Partner, McNeill Baur
Sendil Devadas, PhD, Assistant Chief IP Counsel, Corteva Agriscience
Phil Makrogiannis, Head of IP, Cardinal Health

Welcome Reception
5:30 pm - 7:30 pm  
Ole Red, 300 Broadway, Nashville, TN
For a BIG Nashville welcome join us at the legendary "Ole Red" restaurant.  Enjoy award-winning southern fare and honky-tonk style music, plus a possible Blake Shelton appearance!    

Tuesday, November 19, 2019

Breakfast
8:00 am - 9:00 am

Education Session 2: A Penny for Your Thoughts: Secrets and Strategies for Managing Litigation Budgets
9:00 am - 10:15 am
Sponsored by O'Melveny & Myers LLP

How do biotechnology companies and their law firms control legal spend while ensuring results?  This panel will feature in-house and outside counsel perspectives on the art of budgeting.  Our panel will explore best practices around staffing, reserves, creative AFAs (is the billable hour really dead?), how to deal with surprises, and common cost drivers.  With interactive audience discussion, we will ask: how can those spending a king’s ransom become better bargain shoppers?

Moderator:
Lisa B. Pensabene, Esq., Partner, O'Melveny & Myers LLP

Speakers:
Henry Gu, Chief IP Counsel, Akebia Therapeutics, Inc.
Hassen A. Sayeed, M.D., Partner, O'Melveny & Myers LLP

Refreshment Break
10:15 am - 10:30 am

Education Session 3: In the Hot Seat - Case Law Update and Trends
10:30 am - 11:45 am
Sponsored by Choate Hall & Stewart LLP

This panel will assess the latest from the Supreme Court and Federal Circuit by reviewing cases to watch in the upcoming term and recent developments including the evolving standard of IPR estoppel (various cases), standing to appeal IPR decisions (e.g. Dex Media), objective indicia of obviousness (Acorda Therapeutics) and lost profits as Lanham Act damages (Romag), among other issues.

Moderator:
Eric Marandett, Co-Chair of IP Litigation, Choate Hall & Stewart LLP

Speakers:
Dana Mahadeo, Senior Director, Intellectual Property, Alnylam
Stephanie Schonewald, PhD, Counsel, Choate Hall & Stewart LLP

Networking Lunch Buffet
11:45 am - 1:00 pm   

Education Session 4: What You Need to Know About IP Transactions with Universities & Nonprofits
1:00 pm - 2:15 pm
Sponsored by Venable | Fitzpatrick

We will discuss unique challenges engaging in IP transactions with universities and nonprofit organizations, including license agreements, indemnity provisions, and litigation concerns.  Panelists will include participants from private and public universities and nonprofits.

Moderator:
Ha Kung Wong, Partner, Venable | Fitzpatrick

Speakers:
Ruth Atherton, PhD, JD, Director of Legal, Global Health, Bill & Melinda Gates Foundation
Brion Berman, JD, RTTP, Assistant Director, Technology Transfer, University of Central Florida
Chris Borello, Partner, Venable | Fitzpatrick
Laura Fahey Fritts, Director of License and Patent Strategy & Chief Intellectual Property Officer, Emory University
 

Refreshment Break
2:15 pm - 2:30 pm

Education Session 5: (Trade) Secrets from the Trenches: How to Prepare for and Protect Your Company from Trade Secret Litigation
2:30 pm - 3:45 pm  
Sponsored by Fenwick & West LLP

This panel will provide tips to help you protect your company from trade secret litigation, gleaned from insiders who have experienced it firsthand. The panelists will share their experience and insights into how companies can prepare themselves (where to start, what to consider, how to plan).  The panel will also touch on recent happenings in trade secret law, the availability of criminal remedies, important US cases from the past year, and international perspectives on trade secret litigation.

Moderator:
Ryan Johnson, Partner, Fenwick & West LLP

Happy Hour
3:45 pm -5:00 pm

Activity and Dinner Reception
5:30 pm - 8:30 pm  
Goo Goo Shop, 116 3rd Ave S, Nashville, TN
Who said you can't have dessert before dinner? Take a journey back in time with the Goo Goo Cluster! This Nashville specialty is a delicious combination of marshmallow nougat, caramel, roasted peanuts and real chocolate guaranteed to satisfy your sweet tooth. We'll hear the history behind the chocolate, and enjoy a hands-on experience before a dinner buffet of southern classics!  

Wednesday, November 20, 2019

Breakfast
8:00 am - 8:30 am

Education Session 6:Getting Your (Patent) House in Order: Preparing for Biosimilar Challenges
8:30 am - 9:45 am
Sponsored by Akin Gump Strauss Hauer & Feld LLP

We will discuss concrete steps you can take now to prepare for a future biosimilar challenge, including:

  • Identifying all potentially relevant patents
  • Conducting due diligence of your patent estate to ensure ownership, exclusive licensee status and assertion rights
  • Understanding issues relating to obviousness-type double patenting, terminal disclaimers, and patent term
  • Pursing additional coverage through pending patent applications

Moderator:
Steven Maslowski, Partner, Akin Gump Strauss Hauer & Feld LLP

Speaker:
Ken Dow, Vice President, Pharmaceutical Patent Strategy, Johnson & Johnson
Alysia Finnegan, Counsel, Intellectual Property Group, Merck
Paul Golian, Vice President & Assistant General Counsel, Bristol-Myers Squibb
Matthew Pearson, Partner, Akin Gump Strauss Hauer & Feld LLP

Refreshment Break
9:45 am - 10:00 am

Education Session 7: Section 101 Patent Eligibility: The Good, The Bad, and The Ugly
10:00 am - 11:15 am  
Sponsored by Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

This panel will examine the contours of recent section 101 decisions from the PTAB, district courts, and the Federal Circuit post-January 2019 USPTO guidance, including a review of cases after the Berkheimer/Aatrix decisions.  The panel will also discuss pending legislation concerning patent eligibility and the potential impact on Life Science strategies. 

Moderator:
Robert Shaffer, Partner, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Speakers:
Melanie Baird, Partner, Blake, Cassels & Graydon LLP
David Hoffman, Executive Director, Intellectual Property, Parker Institute for Cancer Immunotherapy
Cora Holt, Attorney, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Program Adjourns
11:15 am

* As of October 7, 2019. Please note this schedule is subject to change.

 

Statement on Diversity

BIO is committed to workforce development, diversity, and inclusion, and incorporates these values into all aspects of BIO operations. Program development for BIO’s events will be considered in this light, with specific attention paid to speakers’ gender, race, ethnic background, sexual orientation, and gender identity, as well as their company’s focus, financing, geographic location, and size.  Diverse programming at BIO’s events allows BIO to remain a strong leader in efforts to ensure that the biotechnology industry can attract, develop, and retain a high-quality, globally competitive employee talent pool. Learn more about Workforce Development, Diversity, & Inclusion at BIO.  

Conferences and Events: 
H1: 
IPCC Fall Schedule of Events

BIO Statement on Hatch-Waxman Integrity Act of 2019

IPCC 2018 Fall Agenda

 IPCC-Fall 2018 Program Agenda 
*As of November 9, 2018

All sessions take place at the Conrad Indianapolis, in the Vienna Ballroom, South, unless otherwise noted.

WEDNESDAY, NOVEMBER 14, 2018

Registration Open
12:00 pm - 4:30 pm

Opening Remarks
Sponsored by: European Patent Office

Remarks by: Klaus-Peter Döpfer, Director, European Patent Office


Opening Session: Cousins Once Removed - What Can Medical Biotechnology Learn from Patent Litigation in Industrial and Agricultural Biotech?
2:00 pm – 3:30 pm

Sponsored by: O'Melveny & Meyers LLP

This panel will discuss recent legal trends in patent litigation involving agricultural and medical biotechnologies.  Using a cross-disciplinary perspective, panelists will review recent key cases, examine how the similarities and differences between industries shape litigation strategy, and offer practical advice.

Moderator: Lisa Pensabene, Partner, O’Melveny & Meyers LLP

Speakers:

  • Raymond Harmuth, Vice President, Bayer CropScience
  • Hassen Sayeed, M.D, Partner, O’Melveny & Myers LLP
  • Letitia Walker, Legal Director - Patents, Merck


Refreshment Break
3:30 pm – 3:45 pm
Sponsored by: 
Marshall Gerstein & Borun LLP


Education Session 1: Obviousness-Type Double Patenting – Where Are We, and Is It Time for a Legislative Clarification?  
3:45 pm – 5:00 pm
Sponsored by: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Obviousness-type double patenting was created to fill a gap in the patent statute, but it has moved beyond that narrow purpose and has threatened otherwise valid and unobvious patents. This panel will discuss the recent case law of the Federal Circuit, strategies to take during prosecution to reduce risk, and legislative efforts to address this problem.   

Moderator: Howard W. Levine, Partner, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Speakers:

  • Robert Armitage, Former General Counsel, Eli Lilly and Company
  • Eyal Barash, Chief Intellectual Property Counsel, Endocyte, Inc
  • Alissa Lipton, Partner, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP


Welcome Reception at Skyline Club
5:30 pm – 7:30 pm
Skyline Club
1 American Square, 36th Floor (.3 miles, 5 minute walk from Conrad Indianapolis)

Sponsored by: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Located on the 36th floor of the One America Building in the heart of downtown Indianapolis, the Skyline Club offers sweeping views of the city’s landscape. Join your colleagues for cocktails and light bites in the club that is hailed as the “most distinguished business dining private club in Indianapolis.” 
Walking group will depart from the Conrad Indianapolis main lobby at 5:25 pm.

Thursday, November 15, 2018

IPCC Business Meeting & Breakfast 
*Open to IP Counsels Committee company members only
8:30 am – 10:15 am


Breakfast Available for all IPCC Attendees
8:30 am – 10:00 am


Education Session 2: Raising the Stakes in Patent Cases
10:30 am – 11:45 am
Sponsored by: Choate Hall & Stewart LLP

From on-sale bar to sovereign immunity, this panel will discuss several recent important cases and their impact on the life sciences community. Specifically, we will review key Supreme Court and Federal Circuit cases addressing challenges associated with enforcement and damages, including: on-sale bar under AIA (Helsinn v. Teva), implications of sovereign immunity in IPR proceedings (U. Minnesota v. LSI), questions around standing to appeal a PTAB decision (Momenta v. BMS), the latest on induced infringement (GSK v. Teva), and the issues of lost foreign profits and apportionment for patent infringement (WesternGeco v. ION Geophysical Corp. and Power Integrations v. Fairchild Semiconductor).

Moderator: Michael Bunis, IP Litigation Co-Chair, Choate Hall & Stewart LLP

Speakers:

  • Cambria Alpha-Cobb, Patent Agent, Momenta Pharmaceuticals
  • Kristen C. Buteau, Counsel, Choate, Hall & Stewart
  • Kevin McGough, Vice President, IP Legal, Shire Pharmaceuticals

Lunch Buffet & Keynote featuring Professor Mark D. Janis, Robert A. Lucas Chair and Professor of Law; Director, Center for Intellectual Property Research, Maurer School of Law, Indiana University 
11:45 am – 1:00 pm
Sponsored by: Brinks Gilson & Lione


Education Session 3: Outcomes, Trends, and Practice Changes in the Patent Trial and Appeal Board 
1:00 pm – 2:15 pm
Sponsored by: Venable|Fitzpatrick

This panel will discuss current IPR statistics with a focus on biologic and small molecule drug IPRs.  This will include statistics on IPR institution rates overall, for biologics and small molecule drugs, and the impact of Patent Owners submitting declarations with their Preliminary responses.  We will also take a look at whether institution rates are changing after the April Supreme Court decision in SAS Institute.  Further discussion will include statistics relating to serial petitions and varying institution and final written decision outcomes based on claim types challenged.

Moderator: Robert S. Schwartz, PhD, Partner, Fitzpatrick

Speakers:

  • Corinne E. Atton, Associate, Fitzpatrick
  • James Harrington, Senior Vice President, Chief Intellectual Property Counsel, Shire Pharmaceuticals
  • Gonzalo Merino, PhD, Chief Intellectual Property Counsel, Regeneron Pharmaceuticals, Inc.


Refreshment Break
2:15 pm – 2:30 pm
Sponsored by: 
Marshall Gerstein & Borun LLP


Education Session 4: The Role of CRISPR in Agricultural, Industrial, and Medical Biotechnology – What Every Patent Practitioner Should Know
2:30 pm – 3:45 pm
Sponsored by: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

While CRISPR technology promises technological breakthroughs in genetic manipulation and the associated treatment of disease, it poses challenges to U.S. Patent law. The panel will discuss these challenges and potential ways to address them. 

Moderator: Howard W. Levine, Partner, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Speakers:

  • Benjamin Gray, Technology and Portfolio Management Lead, Benson Hill Biosystems
  • Amanda Murphy, Ph.D., Partner, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Murray Spruill, Vice President, Intellectual Property, Benson Hill Biosystems


Closing Remarks & Networking Happy Hour (Ballroom Foyer)
3:45 pm – 5:00 pm
Sponsored by: McNeill Baur

Remarks by:  Elizabeth A. Doherty, PhD, Partner, McNeill Baur PLLC

Join your colleagues for a brief happy hour networking session prior to our evening at the Indycar Factory!


Activity and Dinner Reception at Dallara IndyCar Factory
5:30 pm – 8:30 pm
Sponsored byMcDonnell Boehnen Hulbert & Berghoff LLP

Dallara IndyCar Factory
1201 Main St. (5 miles, 15 minute drive from Conrad Indianapolis)

Get your adrenaline pumping with a variety of interactive exhibits and activities centered around the world’s fastest sport. Take in the history and engineering involved in designing, building, and supporting some of the world’s most competitive race cars, and get in the racing spirit with full size Indycar race simulators and a real time pit stop challenge in the Interactive Hall before sitting down to dinner among Indy 500 race cars. Transportation will depart from the Illinois Street exit of the Conrad Indianapolis at 5:15 pm. Return shuttles will depart Dallara Indycar Factory at 8:00 pm and 8:30 pm. 

FRIDAY, NOVEMBER 16, 2018

Breakfast
8:00 am – 8:45 am


Education Session 5: “I’ll be Back.” The FDA’s Biosimilars Action Plan, Regulatory Guidances, and Their Impact on IP
8:30 am – 9:45 am
Sponsored by: Fitzpatrick

This panel will discuss the new FDA Biosimilar Action Plan and stakeholders’ responses as well as recent FDA Guidances concerning biologics, biosimilars and interchangeables and their potential impact on IP from R&D and biologic developments into the future.

Moderator: Ha Kung Wong, Partner, Fitzpatrick

Speakers:

  • Colleen McKiernan, PhD, Associate Director, Intellectual Property, Alnylam Pharmaceuticals
  • Claire Vasios, Vice President, Intellectual Property, Alkermes, Inc. 


Refreshment Break
9:45 am – 10:00 am
Sponsored by: 
Marshall Gerstein & Borun LLP


Education Session 6: Trade Secrets in an Evolving Landscape: Practice Pointers for Biotech Patent Practitioners
10:00 am – 11:15 am
Sponsored by: Choate Hall & Stewart LLP

This panel will discuss recent happenings in trade secret law, including a national uptick in trade secret litigation, important US cases from the past year, and international perspectives on trade secret litigation.

Moderator: Anita Spieth, Counsel, Choate Hall & Stewart LLP

Speakers:

  • Steve Bossone, Vice President, Intellectual Property, Alnylam Pharmaceuticals
  • Kerry Flynn, VP, Chief IP Counsel, Vertex Pharmaceuticals
  • David Wilson, Partner, Carpmaels & Ransford LLP


Program Adjourns 
11:15 am

Conferences and Events: 
H1: 
IPCC 2018 Fall Agenda

Hotel & Conference Venue

 

Le Meridien Denver Downtown
1475 California St.
Denver, CO 80202

Hotel Block

BIO has reserved a block of hotel rooms for registered IP Counsels Committee Conference attendees at the conference hotel, the Le Meridien Denver Downtown, located in the heart of downtown Denver!

The group discount deadline - Monday, March 18 - has passed and the group rate is no longer available. Please check directly with the Le Meridien for current availibility and rates online.

Hotel Amenities

  • In-room Wireless Internet
  • 24-hour Fitness Center
  • Locally acclaimed rooftop bar
Conferences and Events: 
H1: 
Hotel & Conference Venue

BIO Statement on the United States-Mexico-Canada Agreement

First Time Attendee Discount

 

BIO is offering a discount for first time in-house attendees. For a limited number of qualified applicants, BIO will waive the registration fee and reimburse up to $500 in hotel and airline expenses. Recipients must be employed at a R&D biotech company and have never attended a BIO IPCC Conference before.

Are you part of a small in-house IP group or have not had the opportunity to attend a biotech-focused IP conference? This would be a great opportunity to connect with similarly-situated in-house colleagues, get updates and analysis on patent law developments, share best practices, and participate in policy discussions that affect our industry. Please complete the attendee registration form and select the "First Time In-House Counsel" registration rate if you believe you qualify for the discount. 

If accepted, please submit your travel and hotel receipts to kreyes@bio.org within thirty (30) days after the final day of the conference.  Late submissions will not be granted exemptions.

Conferences and Events: 
H1: 
Special Offer for First Time Attendees

Earn CLE Credit


BIO will be offering continuing legal education credit at all IPCC Conferences. Application for CLE credit will be submitted in California and Virginia, and attorneys will be notified when BIO receives credit approval. Attorneys needing CLE credit from Tennessee and other states are welcome to sign in, pick up the CLE forms and apply to their jurisdictions on their own. BIO will provide you with all the materials and documentation required to apply with your individual state CLE Boards.

Conferences and Events: 
H1: 
Attend IPCC and Earn CLE Credit

You Are Now Opted Out

You are Now Opted Out of Email Communications about this Event

You are now opted out of 2018 IPCC communications. Want to opt back in? Please click here to set your email preferences.

Conferences and Events: